Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzzy was a U.S.-based digital pet health company that offered subscription veterinary telehealth, direct-to-consumer pet medications and supplements, and an e-commerce marketplace for wellness products. The company connected pet owners with veterinarians through a mobile-first platform for 24/7 chat and care guidance, and also provided prescription fulfillment and pet care content. Founded in 2016 and based in San Francisco, Fuzzy positioned itself as an accessible, consumer-friendly veterinary care platform for dogs and cats. It raised substantial venture funding and expanded into insurance-related offerings and travel-related partnerships. However, the company shut down operations in 2023 and is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuzzy Pet Health.